FDA Inspection 1251556 — Jessica McCoun
The FDA completed an inspection of Jessica McCoun on Oct 4, 2024 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 4, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional details
Clinical Investigator (CI)